Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,799
Closed -$206K 131
2021
Q1
$206K Hold
2,799
0.23% 112
2020
Q4
$218K Sell
2,799
-275
-9% -$21K 0.25% 98
2020
Q3
$243K Hold
3,074
0.3% 76
2020
Q2
$237K Sell
3,074
-1,289
-30% -$97K 0.3% 77
2020
Q1
$320K Buy
+4,363
New +$343K 0.4% 50

Other funds holding MRK

Indie Asset Partners's MRK Position: Q2 2021 in Review

Indie Asset Partners sold out of Merck (MRK) in Q2 2021, closing a stake of 2,799 shares — an estimated $206K sold.

Indie Asset Partners first reported a position in MRK in Q1 2020 and held it in 5 quarters. The position peaked at $320K in Q1 2020. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Indie Asset Partners reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • Indie Asset Partners sold 2,799 Merck shares in Q2 2021, an estimated $206K.
  • Indie Asset Partners first reported a position in Merck in Q1 2020 and held it in 5 quarters.
  • Indie Asset Partners's Merck position peaked at $320K in Q1 2020.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Indie Asset Partners's 13F filing for Q2 2021, filed 11 Aug 2021.